PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1337517A1
公开(公告)日:2003-08-27
[EN] PYRIMIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF ATHEROSCLEROSIS<br/>[FR] DERIVES DE PYRIMIDINONE ET LEUR UTILISATION DANS LE TRAITEMENT DE L'ATHEROSCLEROSE
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2002030911A1
公开(公告)日:2002-04-18
Compounds of formula (I) are inhibitors of the enzyme Lp-PLA2 and are of use in therapy, in particular for treating athereosclerosis.
PROCESS FOR THE PRODUCTION OF SITAGLIPTIN
申请人:Rasparini Marcello
公开号:US20140081026A1
公开(公告)日:2014-03-20
A novel process is described for the synthesis of Sitagliptin, IUPAC name 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine, of formula (I).